How would you like to own Buzz Aldrin’s FLOWN Inflight Coverall Jacket, which he wore on his mission to the Moon and back during Apollo 11?
Well you can. You also have the opportunity to buy many other space items.
Sotheby’s is having their auction on July 26, 2022 at 12 noon EDT in New York.
Buzz Aldrin’s Jacket – Credit: Sotheby’s
The featured item is Buzz Aldrin’s jacket. The current bid is $700,000, with an estimated sales price of $1,000,000 to $2,000,000.
Other interesting items up for sale in the Buzz Aldrin: American Icon Auction include Buzz Aldrin’s Lifetime Passes to the National and American Leagues of Major League Baseball which has a current bid of $1300, and the United States flag that was flown to the moon on Apollo 11 currently bid at $17,000,.
One other totally unique item is the broken circuit breaker switch that nearly ended the lives of the Apollo 11 Crew, and the pen that saved them, now bid at $700,000.
There are a total of 69 different lot to choose from in this auction.
Do you want to live forever? Many billionaires want to, or at least want to support the research into improving and extending the lives of people.
Paul Allen, co-founder of Microsoft (MSFT) created the Allen Institute for Cell Science with $100 million, to develop treatments for diseases related to aging. Unfortunately, he passed away in 2018 from septic shock caused by cancer.
Google (GOOG) (GOOGL) co-founder Sergey Brin has donated to the Michael J. Fox Foundation and to the Parkinson’s Institute.
There are many companies involved in longevity and life extension through several different approaches, including medical devices, biotechnology, pharmaceuticals, and senior care facilities.
The anti-aging industry is experiencing tremendous growth. The life extension industry is projected by economists to exceed $1 trillion by 2025.
Biotechnology companies are helping people to live longer than ever. This is due in part to efforts in the field of life extension science, which focuses on developing cutting-edge technologies for extending human life. Three technologies of importance in this field are DNA tests to aid in disease prevention, stem cell research, and gene therapy.
Virus
Stem cells allow fetuses to grow complete organs from a single cell. They are used in research to grow transplantable organs. In recent years, scientists have been able to grow replacement body parts and functioning organs. In certain situations, these organs have been successfully transplanted into human patients. Scientists expect that, as this technology continues to advance, the survival rate of patients needing organ transplants will increase dramatically.
One of the challenges in the efforts toward human life extension includes genetic defects that cause fatal diseases. Current research for combating these diseases includes modifying the structure of human DNA through gene therapy. Using gene therapy, scientists can repair damaged DNA by implanting genetic components into human cells.
Some people can inherit a much greater chance of contracting fatal illnesses. With DNA testing, scientists can pinpoint individual genes that cause a high likelihood of developing a specific disease. When locating these harmful genes, fatal diseases can be prevented or treated early enough to prevent death.
Industry experts predict that, at the current rate of advancement, the anti-aging industry may soon surpass that of traditional disease-treating healthcare.
Stocks Targeting Aging
There are several companies working on helping you achieve a greater longevity, which are involved in targeting human aging and degenerative diseases. Here are several that are close to longevity pure plays.
Lineage Cell Therapeutics, Inc. (LCTX) develops and markets therapies for the treatment of various degenerative diseases including age-related macular degeneration, acute spinal cord injuries, non-small cell lung cancer, and various other diseases and disorders. The stock has a market cap of $270 million.
Unity Biotechnology, Inc. (UBX), is a biotechnology company involved in the research and development of therapeutics to extend human life and health. The company’s lead drug candidates include treatments for musculoskeletal/ osteoarthritis disease, moderate-to-severe osteoarthritis of the knee, diabetic macular edema, and ophthalmologic diseases. The stock has a market cap of $47 million.
Cohbar (CWBR) is a clinical stage biotechnology company which concentrates on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases.
CohBars therapeutics offer the potential to treat a broad range of diseases, including nonalcoholic steatohepatitis, obesity, fibrotic diseases, cancer, acute respiratory distress syndrome, type 2 diabetes, and cardiovascular and neurodegenerative diseases. This Menlo Park, California based company was founded in 2007. The stock has a market cap of $16 million.
AgeX Therapeutics, Inc. (AGE) is an Alameda, California based biotechnology company founded in 2017, with a great stock ticker symbol.The company develops and commercializes novel therapeutics targeting human aging.
The company’s two major proprietary technologies can generate pluripotent stem cell-derived young cells of any type for potential application in a range of degenerative diseases of aging with a high unmet medical need. The company has a longevity platform with a goal of unlocking cellular immortality and regenerative capacity to reverse age-related changes in the body. The stock has a market cap of $27 million.
Adicet Bio, Inc. (ACET), has merged with resTORbio, Inc., a Boston, Massachusetts based company founded in 2016, which is involved in developing innovative medicines that target aging to prevent or treat aging-related diseases.
The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. The stock has a market cap of $682 million.
If you are looking for a more diversified way of investing in this arena, there is the ARK Genomic Revolution ETF (ARKG), which invests in companies involved in genomics.
Please be aware that the above mentioned stocks are extremely low cap companies and should be considered very speculative.
Large Companies in Life Extension
There are some large companies involved in longevity and anti-aging.
One company that fits into this category is Edwards Lifesciences (EW), a California based company involved in the production of products to treat heart disease. This $63.7 billion market cap company trades at 41 times trailing earnings.
Boston Scientific (BSX), a $54.5 billion market cap company, makes and markets an extensive array of cardiology products. The stock has a trailing price-to-earnings ratio of 73.
Vertex Pharmaceuticals Incorporated (VRTX) developer and markets treatments for cystic fibrosis. This $71.7 billion market cap stock trades at 30 times earnings.
Terumo Corporation (TRUMY), based in Japan, makes and markets numerous medical products, primarily for transfusion and cardiothoracic surgery. The $29 billion market cap stock has a PE ratio of 39.
CRISPR
One other related narrow industry in this area is CRISPR. If you are not familiar with what this is, you can check out our CRISPR article.
Just be aware that many of the stocks involved in gene therapy, stem cells, and CRISPR are very low cap companies and therefore, very speculative.
Hopefully, one or more of these stocks will provide you with great returns over a long and healthy life. Who knows? You may not live forever, but at least to the age to 200 or 300.
Disclosure : Author didn’t own any of the above at the time the article was written. No recommendations are expressed or implied.
Investors continue to look for high yields on their money. One option that many consider are high yield equity REITs.
A REIT is a Real Estate Investor Trust. A REIT is a company that owns and typically operates income-producing real estate or related assets, such as real estate mortgages.
Properties may include office buildings, shopping malls, apartments, hotels, resorts, self-storage facilities, warehouses, and mortgages or loans.
Office Building in a REIT
Unlike other real estate companies, a REIT does not develop real estate properties to resell them. Instead, a REIT buys and develops properties primarily to operate them as part of its own investment portfolio.
REITS are required to pay out at least 90% of their taxable income to shareholders as dividends each year. However, most REITS pay out at least 100 percent of their taxable income to their shareholders.
The big advantage of REITs is that they avoid double taxation. They are generally not taxed at the corporate level, unlike corporations.
This tends to boost the payout rates for REITs, compared to stocks that are registered as corporations.
There are two primary types of REITs: equity REITs and mortgage REITs.
Equity REITs own the actual buildings and land.
Mortgage REITs own mortgages on the properties. Last week, we published an article on large cap stocks paying over 10% which included some mortgage REITs.
Our researchers have turned up four equity REITs that are currently yielding over 10%.
High Yield Equity REITs
Office Properties Income Trust (OPI) owns, operates, and leases properties to single tenants especially those with excellent credit such as government entities. The annual dividend rate is 11.18%, payable quarterly, and the stock is trading at 65% of book value. Quarterly revenue growth was 2% year-over-year. Earnings have dropped.
Presidio Property Trust (SQFT), which has a great stock ticker symbol, is diversified both geographically and by real estate type, with a portfolio that includes office, industrial, retail and model home residential properties.
The stock pays a dividend yield of 13.59% and the price to book value is 0.21. Earnings per share growth this year was 45.4%; however revenues have been down.
Global Net Lease (GNL) pays a 10.69% yield. Quarterly revenue growth was up 8.6% year-over-year. Quarterly earnings growth rose by an incredible 571.5% year-over-year.
The company has a a diversified global portfolio of commercial properties in the United States and Europe.
Generation Income Properties (GIPR) has a diversified portfolio of office, industrial and retail high quality single tenant properties. The stock pays 10.39%.
Quarterly revenues were up 33.3% and quarterly earnings increased by 71.9%.
The following is a short list of some of the many stocks going ex dividend during the next month.
Many traders and investors use the stock trading technique called ‘Buying Dividends,’ also commonly referred to as ‘Dividend Capture.’ This is the strategy of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend.
This technique generally works in bull markets and flat or choppy markets, but during bear markets, you may want to consider avoiding this strategy. In order to be entitled to the dividend, you have to buy the stock before the ex-dividend date, and you can’t sell the stock until on or after the ex date.
The actual dividend may not be paid for another few weeks. WallStreetNewsNetwork.com has compiled a downloadable list of the stocks going ex dividend in the near future. The list contains many dividend paying companies, lots with market caps over $500 million. Some of the stocks have yields over 2%. Here are a few examples showing the stock symbol, the ex-dividend date, the periodic dividend amount, and the annual yield.
Intel Corporation (INTC)
8/4/2022
0.365
3.63%
MetLife, Inc. (MET)
8/8/2022
0.50
3.29%
Starbucks Corporation (SBUX)
8/11/2022
0.49
2.37%
Target Corporation (TGT)
8/16/2022
1.08
2.82%
Lockheed Martin Corp (LMT)
8/31/2022
2.80
2.87%
The entire list of over 120 ex-dividend stocks will be emailed to all subscribers early next week, on Tuesday, July 26, 2022. If you are not a subscriber, you can sign up at the signup box below. Don’t miss out. Remember, it’s free!
Dividend Definitions
Declaration date: the day that the company declares that there is going to be an upcoming dividend.
Ex-dividend date: the day on which if you buy the stock, you would not be entitled to that particular dividend; or the first day on which a shareholder can sell the shares and still be entitled to the dividend.
Record date: the day when you must be on the company’s books as a shareholder to receive the dividend. The ex-dividend date is normally set for stocks at two business days before the record date.
Payment date: the day on which the dividend payment is actually made, which can be as long at two months after the ex date.
Don’t forget to reconfirm the ex-dividend date with the company before implementing this technique.
Disclosure: Author did not own any of the above at the time the article was written; affiliate links are on this page.
Many investors have been looking for ways to generate higher yields. Unfortunately, other than Series I Bonds, there aren’t many alternatives.
Interest rates are going up for mortgages and credit cards, but as for bank accounts, you are lucky to get over 1% on a certificate of deposit.
However, there are seven profit-making stocks that are currently offering yields of more that 10%.
All of these companies have market caps over $2 billion, have a trailing price to earnings ratio below 14, and a forward P/E ratio less than 15.
AllianceBernstein Holding L.P.(AB) is an asset management company with a market cap of $4.03 billion. The trailing P/E ratio is 10.44, the yield is 11.68%.
Arbor Realty Trust, Inc. (ABR) is a Mortgage Real Estate Investment Trust, also referred to as a mortgage REIT. This $2.32 billion market cap company has a P/E of 7.59, and a yield of 10.74%.
Another mortgage REIT is Chimera Investment Corporation (CIM), with a market cap of $2.15 billion. It trades at 13.19 times earnings and has a generous yield of 13.86%.
FS KKR Capital Corp. (FSK) is a $5.93 billion market cap asset manager with a very low P/E of 2.41. It pays a high yield of 13.26%.
Annaly Capital Management, Inc. (NLY) is yet another mortgage REIT, and has a $9.70 billion market cap. The P/E is a low 3.64, and the yield is a very high 14.26%.
Southern Copper Corporation (SCCO) has a market cap of $37.12 billion. This copper producer trades at 11.1 times earnings and yields 10.65%.
Last but not least, UWM Holdings Corporation (UWMC) is a mortgage finance company with a market cap of $5.50 billion. The P/E is 6.38, and the yield is 11.46%.
Beware of High Yield Issues
A few thing to be aware of regarding these high yields:
• The dividends are subject to change and elimination • Putting limited partnerships (such as AllianceBernstein) in a qualified plan, such as an IRA, may have adverse tax consequences. (Talk to your account about this issue) • Often there is a negative reason for stocks to trade at very high yields • Many mortgage REITs use leverage to boost their yields, which creates added risk
Before making a rash decision about investing in any of these companies, do some research on them and be aware of the risks.
Disclosure: Author didn’t own any of the above at the time the article was written.
Have you ever wondered what the old websites look like for various companies? The Tesla.com website has had a few dramatic changes over the years, because for a long time, the domain name wasn’t even owned by Elon Musk’s Tesla (TSLA) company.
The following shows what the old home pages looked like for Tesla.com:
Forget tiny houses. The perfect location is available to you in Palm Beach.
The mansion that was owned by conservative talk show host Rush Limbaugh is up for sale, according to ZeroHedge and the Wall Street Journal. Limbaugh passed away last year.
The home sits on a lot over two acres, and has over 16,000 square feet of living space, according to Zillow. It reportedly has 20 bathrooms.
The asking price is between $150 million to $175 million.
Now is your chance to put your money into something totally unique. Steve Jobs autograph on a 1984 Macintosh System Disk Version 1.0.
This outstanding item is being offered by the Paris, France auction house, Pierre Bergé & Associés.
This is a floppy disk of the very first Macintosh software operating system from 1984 and dedicated by Steve Jobs.
Steve Jobs – Credit: Pierre Bergé & Associés
It is inscribed as “To André Steve Jobs”.
In addition, included in the lot is a 1984 floppy disk, unsigned, for MacWrite and MacPaint.
This auction lot as an estimate of €10,000 to €20,000, with a starting bid of €8,000.
The original Macintosh was the first successful mass-market all-in-one desktop personal computer to have featured a graphical user interface, built-in screen, and mouse.
Apple Computer (now Apple Inc.) first started selling the Mac in January of 1984.
If you are into technology and autographs, this rare item is for you.
